Stroke care company Imperative Care Inc revealed on Friday the appointment of Daniel Davis as its chief operating officer.
In the senior position in the company, Davis is responsible for the launch and growth of the breakthrough technologies to treat ischemic stroke patients in the US.
Most recently, Davis has served as chief commercial officer and president of North America, Penumbra, where he launched the first FDA-cleared aspiration system for neurovascular mechanical thrombectomy.
The company said Davis brings 19 years of experience in sales, marketing, and business development with both early stage and Fortune 500 medical device, technology and consumer product companies, focused on bringing neurovascular innovations to market.
Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA
Formosa Pharmaceuticals licenses APP13007 ophthalmic therapy to Samil for South Korea
Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer
Sanofi's Teizeild approved in EU to delay stage 3 type 1 diabetes
Renalytix expands US clinical footprint with three kidneyintelX.dkd integrations
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics
FDA accepts NDA resubmission for Camurus' acromegaly drug Oclaiz
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Arbele's ARB1002 receives US FDA Orphan Drug Designation
Compass Pathways wins FDA IND acceptance for COMP360 PTSD trial